535 related articles for article (PubMed ID: 10406466)
21. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
22. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
23. The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor.
Kokabu S; Nakatomi C; Matsubara T; Ono Y; Addison WN; Lowery JW; Urata M; Hudnall AM; Hitomi S; Nakatomi M; Sato T; Osawa K; Yoda T; Rosen V; Jimi E
J Biol Chem; 2017 Aug; 292(31):12885-12894. PubMed ID: 28607151
[TBL] [Abstract][Full Text] [Related]
24. Myogenic basic helix-loop-helix proteins regulate the expression of peroxisomal proliferator activated receptor-gamma coactivator-1alpha.
Chang JH; Lin KH; Shih CH; Chang YJ; Chi HC; Chen SL
Endocrinology; 2006 Jun; 147(6):3093-106. PubMed ID: 16527841
[TBL] [Abstract][Full Text] [Related]
25. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR.
Baniahmad A; Dressel U; Renkawitz R
Mol Endocrinol; 1998 Apr; 12(4):504-12. PubMed ID: 9544986
[TBL] [Abstract][Full Text] [Related]
26. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
27. Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors.
Azmi S; Ozog A; Taneja R
J Biol Chem; 2004 Dec; 279(50):52643-52. PubMed ID: 15448136
[TBL] [Abstract][Full Text] [Related]
28. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.
Sun L; Liu L; Yang XJ; Wu Z
J Cell Sci; 2004 Jun; 117(Pt 14):3021-9. PubMed ID: 15173318
[TBL] [Abstract][Full Text] [Related]
29. MyoD synergizes with the E-protein HEB beta to induce myogenic differentiation.
Parker MH; Perry RL; Fauteux MC; Berkes CA; Rudnicki MA
Mol Cell Biol; 2006 Aug; 26(15):5771-83. PubMed ID: 16847330
[TBL] [Abstract][Full Text] [Related]
30. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD.
Kong Y; Flick MJ; Kudla AJ; Konieczny SF
Mol Cell Biol; 1997 Aug; 17(8):4750-60. PubMed ID: 9234731
[TBL] [Abstract][Full Text] [Related]
31. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
Zhang D; Yoon HG; Wong J
Mol Cell Biol; 2005 Aug; 25(15):6404-14. PubMed ID: 16024779
[TBL] [Abstract][Full Text] [Related]
32. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.
Lenormand JL; Benayoun B; Guillier M; Vandromme M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1997 Feb; 17(2):584-93. PubMed ID: 9001211
[TBL] [Abstract][Full Text] [Related]
33. MyoD functions as a transcriptional repressor in proliferating myoblasts.
Chu C; Cogswell J; Kohtz DS
J Biol Chem; 1997 Feb; 272(6):3145-8. PubMed ID: 9013546
[TBL] [Abstract][Full Text] [Related]
34. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.
Langley B; Thomas M; Bishop A; Sharma M; Gilmour S; Kambadur R
J Biol Chem; 2002 Dec; 277(51):49831-40. PubMed ID: 12244043
[TBL] [Abstract][Full Text] [Related]
35. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis.
Froeschlé A; Alric S; Kitzmann M; Carnac G; Auradé F; Rochette-Egly C; Bonnieu A
Oncogene; 1998 Jul; 16(26):3369-78. PubMed ID: 9692544
[TBL] [Abstract][Full Text] [Related]
37. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
38. Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6.
Busch K; Martin B; Baniahmad A; Martial JA; Renkawitz R; Muller M
Mol Endocrinol; 2000 Feb; 14(2):201-11. PubMed ID: 10674394
[TBL] [Abstract][Full Text] [Related]
39. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
40. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain.
van der Laan S; Lachize SB; Schouten TG; Vreugdenhil E; de Kloet ER; Meijer OC
Brain Res; 2005 Oct; 1059(2):113-21. PubMed ID: 16212947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
